Table 1:
CT and MRI findings of GLA, KLA, and GSD.
| Patient number/age/sex | Diagnosis | Exam | Number of FSLs on CT | MD of FPLs on CT | Ascites | |
|---|---|---|---|---|---|---|
| Mean (mm) | Range (mm) | |||||
| 1/7/M | GLA | uCT/uMR | 10 | 5 | 2−18 | − |
| 2/12/M | GLA | uCT | 0 | NA | NA | − |
| 3/13/F | GLA | uCT/eMR | 0 | NA | NA | − |
| 4/15/F | GLA | uCT/uMR | 16 | 19 | 7−39 | − |
| 5/25/F | GLA | eCT | 189 | 8 | 3−25 | − |
| 6/25/F | GLA | eCT | 0 | NA | NA | − |
| 7/27/F | GLA | uCT/eMR | 61 | 9 | 4−22 | − |
| 8/31/F | GLA | uCT | 0 | NA | NA | − |
| 9/32/M | GLA | uMR | NA | NA | NA | − |
| 10/33/F | GLA | eCT | 0 | NA | NA | + |
| 11/5/F | KLA | eCT/eMR | 13 | 3 | 2−4 | + |
| 12/7/M | KLA | uCT/uMR | 0 | NA | NA | − |
| 13/8/M | KLA | eCT | 21 | 3 | 2−5 | + |
| 14/15/M | KLA | eCT | 0 | NA | NA | + |
| 15/18/M | KLA | eCT/eMR | 2 | 4 | 4 | + |
| 16/7/M | GSD | eCT | 20 | 4 | 2−6 | − |
| 17/8/M | GSD | eCT | 0 | NA | NA | − |
| 18/19/M | GSD | uCT | 0 | NA | NA | − |
| 19/19/F | GSD | uCT/uMR | 0 | NA | NA | − |
| 20/19/F | GSD | eCT | 0 | NA | NA | − |
| 21/21/M | GSD | uCT | 0 | NA | NA | − |
| 22/39/M | GSD | uCT | 0 | NA | NA | − |
| 23/46/M | GSD | uCT | 0 | NA | NA | − |
GLA: Generalized lymphatic anomaly, KLA: Kaposiform lymphangiomatosis, GSD: Gorham-Stout disease, FSL: Focal splenic lesion, MD: maximum diameter, uCT: Unenhanced CT, eCT: Enhanced CT, uMR: Unenhanced MRI, eMR: Enhanced MRI, NA: Not available